Firefly Neuroscience (AIFF) Gains from Investment Securities (2016 - 2025)
Historic Gains from Investment Securities for Firefly Neuroscience (AIFF) over the last 12 years, with Q3 2025 value amounting to $464939.0.
- Firefly Neuroscience's Gains from Investment Securities fell 2033.03% to $464939.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $464939.0, marking a year-over-year decrease of 2033.03%. This contributed to the annual value of $470061.0 for FY2024, which is 24992.22% up from last year.
- Latest data reveals that Firefly Neuroscience reported Gains from Investment Securities of $464939.0 as of Q3 2025, which was down 2033.03% from $470061.0 recorded in Q4 2024.
- Firefly Neuroscience's Gains from Investment Securities' 5-year high stood at $912000.0 during Q1 2022, with a 5-year trough of -$942609.0 in Q2 2022.
- Over the past 5 years, Firefly Neuroscience's median Gains from Investment Securities value was $383719.5 (recorded in 2021), while the average stood at $304350.7.
- Its Gains from Investment Securities has fluctuated over the past 5 years, first plummeted by 44591.16% in 2022, then surged by 44496.95% in 2023.
- Over the past 5 years, Firefly Neuroscience's Gains from Investment Securities (Quarter) stood at $302500.0 in 2021, then plummeted by 56.63% to $131200.0 in 2022, then grew by 2.39% to $134333.0 in 2023, then soared by 249.92% to $470061.0 in 2024, then decreased by 1.09% to $464939.0 in 2025.
- Its last three reported values are $464939.0 in Q3 2025, $470061.0 for Q4 2024, and $583583.0 during Q3 2024.